Archer Investment Corporation’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.77M | Hold |
73,546
| – | – | 0.34% | 57 |
|
|
2026
Q1 | $2.07M | Buy |
73,546
+100
| +0.1% | +$2.66K | 0.44% | 48 |
|
|
2025
Q4 | $1.83M | Buy |
73,446
+5,774
| +9% | +$146K | 0.41% | 53 |
|
|
2025
Q3 | $1.72M | Buy |
67,672
+18,281
| +37% | +$451K | 0.39% | 52 |
|
|
2025
Q2 | $1.2M | Buy |
49,391
+21,048
| +74% | +$491K | 0.29% | 73 |
|
|
2025
Q1 | $718K | Sell |
28,343
-944
| -3% | -$24.7K | 0.19% | 105 |
|
|
2024
Q4 | $777K | Sell |
29,287
-33,232
| -53% | -$901K | 0.21% | 91 |
|
|
2024
Q3 | $1.81M | Sell |
62,519
-6,484
| -9% | -$189K | 0.49% | 46 |
|
|
2024
Q2 | $1.93M | Buy |
69,003
+4,012
| +6% | +$110K | 0.56% | 41 |
|
|
2024
Q1 | $1.8M | Buy |
64,991
+8,523
| +15% | +$237K | 0.54% | 44 |
|
|
2023
Q4 | $1.63M | Buy |
56,468
+4,400
| +8% | +$133K | 0.52% | 43 |
|
|
2023
Q3 | $1.73M | Buy |
52,068
+3,555
| +7% | +$126K | 0.61% | 37 |
|
|
2023
Q2 | $1.78M | Buy |
48,513
+4,083
| +9% | +$159K | 0.63% | 36 |
|
|
2023
Q1 | $1.76M | Hold |
44,430
| – | – | 0.65% | 34 |
|
|
2022
Q4 | $2.28M | Buy |
44,430
+1,223
| +3% | +$58.6K | 0.88% | 20 |
|
|
2022
Q3 | $1.89M | Buy |
43,207
+550
| +1% | +$26.7K | 0.8% | 24 |
|
|
2022
Q2 | $2.24M | Buy |
42,657
+1,488
| +4% | +$75.8K | 0.91% | 21 |
|
|
2022
Q1 | $2.14M | Buy |
41,169
+877
| +2% | +$45.5K | 0.76% | 26 |
|
|
2021
Q4 | $2.38M | Buy |
40,292
+166
| +0.4% | +$8.22K | 0.81% | 23 |
|
|
2021
Q3 | $1.73M | Buy |
40,126
+2,926
| +8% | +$130K | 0.65% | 28 |
|
|
2021
Q2 | $1.46M | Sell |
37,200
-4,090
| -10% | -$159K | 0.57% | 36 |
|
|
2021
Q1 | $1.5M | Sell |
41,290
-5,471
| -12% | -$194K | 0.62% | 29 |
|
|
2020
Q4 | $1.72M | Buy |
46,761
+2,902
| +7% | +$106K | 0.82% | 24 |
|
|
2020
Q3 | $1.53M | Buy |
43,859
+3,978
| +10% | +$139K | 0.79% | 25 |
|
|
2020
Q2 | $1.24M | Buy |
39,881
+67
| +0.2% | +$2.28K | 0.7% | 29 |
|
|
2020
Q1 | $1.23M | Buy |
39,814
+8,187
| +26% | +$279K | 0.83% | 23 |
|
|
2019
Q4 | $1.18M | Buy |
31,627
+691
| +2% | +$24.6K | 0.62% | 33 |
|
|
2019
Q3 | $1.05M | Sell |
30,936
-8,432
| -21% | -$307K | 0.64% | 35 |
|
|
2019
Q2 | $1.62M | Buy |
39,368
+528
| +1% | +$21K | 1.03% | 16 |
|
|
2019
Q1 | $1.56M | Buy |
38,840
+632
| +2% | +$25.3K | 1.06% | 13 |
|
|
2018
Q4 | $1.58M | Buy |
+38,208
| New | +$1.59M | 1.38% | 10 |
|
Other funds holding PFE
Archer Investment Corporation's PFE Position: Q2 2026 in Review
Archer Investment Corporation held its Pfizer (PFE) position steady in Q2 2026 at 73,546 shares worth $1.77M. The position accounts for 0.34% of the portfolio, ranked #57.
Archer Investment Corporation first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.38M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Archer Investment Corporation held 73,546 shares of Pfizer worth $1.77M as of Q2 2026.
- Archer Investment Corporation left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.34% of Archer Investment Corporation's portfolio in Q2 2026, its #57 holding.
- Archer Investment Corporation first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Archer Investment Corporation's Pfizer position peaked at $2.38M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.